2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., Waku, K.·1995·Biochemical and Biophysical Research Communications

Cited by (1,009)

Items 501–600 of 1,009

  1. Evidence for Specificity in Lipid-Rhodopsin Interactions
    Olivier Soubias, Walter E. Teague, Klaus Gawrisch · 2006 · Journal of Biological Chemistry
  2. Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas
    Chen Li, Peter M. Jones, Shanta Jean Persaud · 2010 · Pharmacology & Therapeutics
  3. An acid amidase hydrolyzing anandamide as an endogenous ligand forcannabinoid receptors
    Natsuo Ueda, K Yamanaka, Y Terasawa, Shozo Yamamoto · 1999 · FEBS Letters
  4. Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome
    Wong, Banny S., Camilleri, Michael, Busciglio, Irene, Carlson, Paula, Szarka, Lawrence A., Burton, Duane, Zinsmeister, Alan R. · 2011 · Gastroenterology
  5. Type-1 Cannabinoid Receptor Signaling in Neuronal Development
    Anne-Lise Gaffuri, Delphine Ladarré, Zsolt Lenkei · 2012 · Pharmacology
  6. Molecular and Morphological Configuration for 2-Arachidonoylglycerol-Mediated Retrograde Signaling at Mossy Cell–Granule Cell Synapses in the Dentate Gyrus
    Motokazu Uchigashima, Maya Yamazaki, Miwako Yamasaki, Asami Tanimura, Kenji Sakimura, Masanobu Kano, Masahiko Watanabe · 2011 · Journal of Neuroscience
  7. Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System
    Shana M. Augustin, David M. Lovinger · 2018 · ACS Chemical Neuroscience
  8. Vascular targets for cannabinoids: animal and human studies
    Christopher P. Stanley, Saoirse Elizabeth O’Sullivan · 2013 · British Journal of Pharmacology
  9. Pharmacotherapeutic targeting of the endocannabinoid signaling system: Drugs for obesity and the metabolic syndrome
    Kiran V. Vemuri, David R. Janero, Alexandros Makriyannis · 2007 · Physiology & Behavior
  10. The Highly Selective Production of 2-Arachidonoyl Lysophosphatidylcholine Catalyzed by Purified Calcium-independent Phospholipase A2γ
    Wei Yan, Christopher M. Jenkins, Xianlin Han, David J. Mancuso, Harold F. Sims, Kui Yang, Richard W. Gross · 2005 · Journal of Biological Chemistry
  11. Lipid Signaling and Synaptic Plasticity
    Nan Sang, Chu Chen · 2006 · The Neuroscientist
  12. Effects of cannabis on cognitive function in patients with multiple sclerosis
    Kimia Honarmand, Mary Catherine Tierney, Paul W O'Connor, Anthony Feinstein · 2011 · Neurology
  13. Fatty Acid Amide Hydrolase: A Gate-Keeper of the Endocannabinoid System
    Fezza, Filomena, De Simone, Chiara, Amadio, Daniele, Maccarrone, Mauro · 2008 · Subcellular Biochemistry
  14. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation
    Haibin Wang, Huirong Xie, Xiaofei Sun, Philip J. Kingsley, Lawrence J. Marnett, Benjamin F. Cravatt, Sudhansu K. Dey · 2006 · Prostaglandins & Other Lipid Mediators
  15. Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells
    Takayuki Sugiura, Shinji Nakane, Seishi Kishimoto · 1999 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  16. Phytocannabinoids in <i>Cannabis sativa</i>: Recent Studies on Biosynthetic Enzymes
    Taura, Futoshi, Sirikantaramas, Supaart, Shoyama, Yoshinari, Shoyama, Yukihiro, Morimoto, Satoshi · 2007 · Chemistry &amp; Biodiversity
  17. In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake
    Eva de Lago, Alessia Ligresti, Giorgio Ortar, Enrico Morera, Ana Cabranes, Gareth Pryce, Maurizio Bifulco, David Baker, Javier Fernández‐Ruíz, Vincenzo Di Marzo · 2003 · European Journal of Pharmacology
  18. Chapter 8 Novel Endogenous N‐Acyl Glycines
    Heather B. Bradshaw, Neta Rimmerman, Sherry Shu‐Jung Hu, SUMNER H. BURSTEIN, James M. Walker · 2009 · Vitamins and hormones
  19. Monoacylglycerol lipase – a target for drug development?
    CJ Fowler · 2012 · British Journal of Pharmacology
  20. Molecular Mechanism and Cannabinoid Pharmacology
    Lesley D. Schurman, Dai Lu, Debra A. Kendall, A­llyn C. Howlett, Aron H. Lichtman · 2019 · Handbook of experimental pharmacology
  21. The inhibition of monoacylglycerol lipase by URB602 showed an anti‐inflammatory and anti‐nociceptive effect in a murine model of acute inflammation
    Comelli, F, Giagnoni, G, Bettoni, I, Colleoni, M, Costa, B · 2007 · British Journal of Pharmacology
  22. Endocannabinoid system involvement in brain reward processes related to drug abuse
    Marcello Solinas, Sevil Yaşar, Steven R. Goldberg · 2007 · Pharmacological Research
  23. Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth
    Sharon DeMorrow, Shannon S. Glaser, Heather Francis, Julie K Venter, Bradley T. Vaculin, Shelley Vaculin, Gianfranco D. Alpini · 2007 · Journal of Biological Chemistry
  24. Ether‐linked analogue of 2‐arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species
    Saori Oka, Akiko Tsuchie, Akira Tokumura, Mayumi Muramatsu, Yoshitomo Suhara, Hiroaki Takayama, Keizo Waku, Takayuki Sugiura · 2003 · Journal of Neurochemistry
  25. Characterization of the Diarylether Sulfonylester (−)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a Potent Cannabinoid Receptor Agonist with Neuroprotective Properties
    Frank Mauler, Joachim Mittendorf, Ervin Horváth, Jean De Vry · 2002 · Journal of Pharmacology and Experimental Therapeutics
  26. Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55
    Raquel Guerrero Alba, Paulino Barragán‐Iglesias, Abimael González‐Hernández, Eduardo E. Valdez-Moráles, Vinicio Granados‐Soto, Miguel Condés‐Lara, Martín Gerardo Rodríguez, Bruno A. Marichal‐Cancino · 2019 · Frontiers in Pharmacology
  27. Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
    Giulia Abate, Daniela Letizia Uberti, Simone Tambaro · 2021 · Biology
  28. Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine
    Daniela Viganò, Marta Valenti, Maria Grazia Cascio, Vincenzo Di Marzo, Daniela Parolaro, Tiziana Rubino · 2004 · European Journal of Neuroscience
  29. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB1 cannabinoid receptor
    Justin P. Meschler, Dennis M. Kraichely, Gerald H. Wilken, A­llyn C. Howlett · 2000 · Biochemical Pharmacology
  30. Molecular model of cannabis sensitivity in developing neuronal circuits
    Erik Keimpema, Ken Mackie, Tibor Harkany · 2011 · Trends in Pharmacological Sciences
  31. Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome‐diarrhea
    Banny S. Wong, Michael Camilleri, Deborah J. Eckert, P. Carlson, Michael D. Ryks, Duane D. Burton, Alan R. Zinsmeister · 2012 · Neurogastroenterology & Motility
  32. Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation?
    Leah M. Mayo, Christine A. Rabinak, Matthew N. Hill, Markus A Heilig · 2021 · Biological Psychiatry
  33. Effects of Peripheral Cannabinoid Receptor Ligands on Motility and Polarization in Neutrophil-like HL60 Cells and Human Neutrophils
    Rina Kurihara, Yumi Tohyama, Satoshi Matsusaka · 2006 · Journal of Biological Chemistry
  34. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators
    Iain M. Brown, Maria Grazia Cascio, Dino Rotondo, Roger G. Pertwee, Steven D. Heys, Klaus W.J. Wahle · 2012 · Progress in Lipid Research
  35. Cannabinoid system in the skin – a possible target for future therapies in dermatology
    Piotr Kupczyk, Adam Reich, Jacek Cezary Szepietowski · 2009 · Experimental Dermatology
  36. Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia
    Rita Nyilas, Laura C. Gregg, Ken Mackie, Masahiko Watanabe, Andreas Zimmer, Andrea G. Hohmann, István Katona · 2009 · European Journal of Neuroscience
  37. Endocannabinoid System: Emerging Role from Neurodevelopment to Neurodegeneration
    Balapal S. Basavarajappa, Ralph A. Nixon, Ottavio Arancio · 2009 · Mini-Reviews in Medicinal Chemistry
  38. Mouse models of preterm birth: suggested assessment and reporting guidelines†
    Ronald McCarthy, Carmel Annette Martin‐Fairey, Dorothy K. Sojka, Erik D. Herzog, Emily S. Jungheim, Molly J. Stout, Justin C. Fay, Mala Mahendroo, Jeff Reese, Jennifer L. Herington et al. · 2018 · Biology of Reproduction
  39. Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: A non-genomic anti-inflammatory switch
    Renato Malcher‐Lopes, Alier J. Franco, Jeffrey G. Tasker · 2008 · European Journal of Pharmacology
  40. Endocannabinoids: A New Family of Lipid Mediators Involved in the Regulation of Neural Cell Development
    Ismael Galve‐Roperh, Tania Aguado, Daniel Rueda, Guillermo Velasco, Manuel Guzmán · 2006 · Current Pharmaceutical Design
  41. The role of the endocannabinoid system in the control of energy homeostasis
    Douglas Osei‐Hyiaman, Judith Dale Harvey-White, Sándor Bátkai, George Kunos · 2006 · International Journal of Obesity
  42. Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
    Sidhpura, Nimish, Parsons, Loren H. · 2011 · Neuropharmacology
  43. Dietary Linoleic Acid Elevates the Endocannabinoids 2‐AG and Anandamide and Promotes Weight Gain in Mice Fed a Low Fat Diet
    Anita Røyneberg Alvheim, Bente E. Torstensen, Yu Hong Lin, Haldis H. Lillefosse, Erik‐Jan Lock, Lise Madsen, Livar Frøyland, Joseph R. Hibbeln, Marian Kjellevold · 2013 · Lipids
  44. Inhibition of Monoacylglycerol Lipase Attenuates Nonsteroidal Anti-Inflammatory Drug-Induced Gastric Hemorrhages in Mice
    Steven G. Kinsey, Daniel K. Nomura, Scott T. O’Neal, Jonathan Z. Long, Anu Mahadevan, Benjamin F. Cravatt, John R. Grider, Aron H. Lichtman · 2011 · Journal of Pharmacology and Experimental Therapeutics
  45. Endocannabinoids: A Promising Impact for Traumatic Brain Injury
    Lesley D. Schurman, Aron H. Lichtman · 2017 · Frontiers in Pharmacology
  46. The Endocannabinoid 2-Arachidonoylglycerol Is Responsible for the Slow Self-Inhibition in Neocortical Interneurons
    Silvia Marinelli, Simone Pacioni, Tiziana Bisogno, Vincenzo Di Marzo, David A. Prince, John R. Huguenard, Alberto Bacci · 2008 · Journal of Neuroscience
  47. Rising stars: Modulation of brain functions by astroglial type‐1 cannabinoid receptors
    Mathilde Metna‐Laurent, Giovanni Marsicano · 2014 · Glia
  48. The endocannabinoid system as a target for the treatment of cannabis dependence
    Jason R. Clapper, Regina A. Mangieri, Daniele Piomelli · 2008 · Neuropharmacology
  49. Evidence for the Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in 12-O-Tetradecanoylphorbol-13-acetate-induced Acute Inflammation in Mouse Ear
    Saori Oka, Yanagimoto Shin, Shinobu Ikeda, Maiko Gokoh, Seishi Kishimoto, Keizo Waku, Yoshio Ishima, Takayuki Sugiura · 2005 · Journal of Biological Chemistry
  50. The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone
    WM Olango, Michelle Roche, GK Ford, Brendan Harhen, David P. Finn · 2011 · British Journal of Pharmacology
  51. Endothelin‐1 increases 2‐arachidonoyl glycerol (2‐AG) production in astrocytes
    Lisa Marie Walter, Nephi Stella · 2003 · Glia
  52. Effects of CB1 cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity
    Cecilia J. Hillard, Shanmugam Muthian, Christopher S. Kearn · 1999 · FEBS Letters
  53. Analysis of endocannabinoids by Ag+ coordination tandem mass spectrometry
    Philip J. Kingsley, Lawrence J. Marnett · 2003 · Analytical Biochemistry
  54. The constitutive production of the endocannabinoid 2‐arachidonoylglycerol participates in oligodendrocyte differentiation
    Oscar Gómez, Ángel Arévalo‐Martín, Daniel García‐Ovejero, Silvia Ortega‐Gutiérrez, Jose Antonio Cisneros, Guillermina Almazán, Maria A. Sanchez-Rodriguez, Francisco Molina‐Holgado, Eduardo Molina‐Holgado · 2010 · Glia
  55. Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors
    Gitte Lindved Petersen, Camilla Sørensen, Patricia C. Schmid, Andreas Artmann, Mads Tang‐Christensen, Steen Honoré Hansen, Philip Just Larsen, Harald H.O. Schmid, Harald Severin Hansen · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  56. Covalent Inhibitors of Human Monoacylglycerol Lipase: Ligand-Assisted Characterization of the Catalytic Site by Mass Spectrometry and Mutational Analysis
    Nikolai Zvonok, Lakshmipathi Pandarinathan, John S. Williams, Meghan Johnston, Ioannis L. Karageorgos, David R. Janero, Srinivasan C. Krishnan, Alexandros Makriyannis · 2008 · Chemistry & Biology
  57. CB1 receptor antagonism: biological basis for metabolic effects
    Vincenzo Di Marzo · 2008 · Drug Discovery Today
  58. Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis
    Athanasios I. Lourbopoulos, Nikolaos Grigoriadis, Roza Lagoudaki, Olga Touloumi, Eleni Polyzoidou, Ioannis Mavromatis, Nikolaos Tascos, Aviva Breuer, Haim Ovadia, Dimitris Karussis et al. · 2011 · Brain Research
  59. Identification of the CB1 Cannabinoid Receptor and Fatty Acid Amide Hydrolase (FAAH) in the Human Placenta
    B Park, H.M. Gibbons, Murray David Mitchell, Michelle Glass · 2003 · Placenta
  60. Anatomical Distribution of Receptors, Ligands and Enzymes in the Brain and in the Spinal Cord: Circuitries and Neurochemistry
    Giovanni Marsicano, Rohini Kuner · 2007 · Springer eBooks
  61. Inhibition of fatty acid amide hydrolase produces PPAR‐α‐mediated analgesia in a rat model of inflammatory pain
    Devi Rani Sagar, D A Kendall, Victoria Chapman · 2008 · British Journal of Pharmacology
  62. Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives
    Simone Tambaro, Marco Bortolato · 2011 · Recent Patents on CNS Drug Discovery
  63. Expression and function of fatty acid amide hydrolase in prostate cancer
    Michael P. Endsley, Rebecca Thill, Iffat Choudhry, Carol L. Williams, Andre Kajdacsy‐Balla, William B. Campbell, Kasem Nithipatikom · 2008 · International Journal of Cancer
  64. Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea
    Linda A. Parker, Raphael Mechoulam, Coralynne Schlievert, Laura Abbott, Melissa A. Fudge, Page Burton · 2003 · Psychopharmacology
  65. Cannabinoids and ceramide: Two lipids acting hand-by-hand
    Guillermo Velasco, Ismael Galve‐Roperh, Cristina Sánchez, Cristina Blázquez, Amador Haro, Manuel Guzmán · 2005 · Life Sciences
  66. Activation of PAF receptors results in enhanced synthesis of 2‐arachidonoylglycerol (2‐AG) in immune cells
    Evgueni V. Berdyshev, Patricia C. Schmid, Randy J. Krebsbach, Harald H.O. Schmid · 2001 · The FASEB Journal
  67. Monoacylglycerol signalling and ABHD6 in health and disease
    Pegah Poursharifi, S.R. Murthy Madiraju, Marc Prentki · 2017 · Diabetes Obesity and Metabolism
  68. The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation
    Alexander P. Young, Eileen M. Denovan‐Wright · 2022 · Frontiers in Pharmacology
  69. Quantitative Method for the Profiling of the Endocannabinoid Metabolome by LC-Atmospheric Pressure Chemical Ionization-MS
    John S. Williams, JodiAnne T. Wood, Lakshmipathi Pandarinathan · 2007 · Analytical Chemistry
  70. The Role of the Brain's Endocannabinoid System in Pain and Its Modulation by Stress
    Louise Corcoran, Michelle Roche, David P. Finn · 2015 · International review of neurobiology
  71. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities
    Samridhi Lal, Anusmita Shekher, Puneet, Acharan Singh Narula, Heidi Abrahamse, Subash C. Gupta · 2020 · Pharmacological Research
  72. Binding and Inactivation Mechanism of a Humanized Fatty Acid Amide Hydrolase by α-Ketoheterocycle Inhibitors Revealed from Cocrystal Structures
    Mauro Mileni, Joie Garfunkle, Jessica K. DeMartino, Benjamin F. Cravatt, Dale L. Boger, Raymond C. Stevens · 2009 · Journal of the American Chemical Society
  73. Epigenetic mechanisms and endocannabinoid signalling
    Claudio D’Addario, Andrea Di Francesco, Mariangela Pucci, Alessandro Finazzi‐Agrò, Mauro Maccarrone · 2013 · FEBS Journal
  74. Missing Pieces to the Endocannabinoid Puzzle
    Mauro Maccarrone · 2019 · Trends in Molecular Medicine
  75. Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels
    Eva de Lago, Stefania Petrosino, Marta Valenti, Enrico Morera, Silvia Ortega‐Gutiérrez, Javier Fernández‐Ruíz, Vincenzo Di Marzo · 2005 · Biochemical Pharmacology
  76. Tetrahydrolipstatin Analogues as Modulators of Endocannabinoid 2-Arachidonoylglycerol Metabolism
    Giorgio Ortar, Tiziana Bisogno, Alessia Ligresti, Enrico Morera, Marianna Nalli, Vincenzo Di Marzo · 2008 · Journal of Medicinal Chemistry
  77. PRECLINICAL STUDY: FULL ARTICLE: Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR‐α nuclear receptors
    Antonio Luchicchi, Salvatore Lecca, Stefano Carta, Giuliano Pillolla, Anna Lisa Muntoni, Sevil Yaşar, Steven R. Goldberg, Marco Pistis · 2010 · Addiction Biology
  78. The CB1 Receptor as the Cornerstone of Exostasis
    Pier Vincenzo Piazza, Daniela Cota, Giovanni Marsicano · 2017 · Neuron
  79. Dark Classics in Chemical Neuroscience: Δ 9 -Tetrahydrocannabinol
    Samuel D. Banister, Jonathon Carl Arnold, Mark A. Connor, Michelle Glass, Iain S. McGregor · 2019 · ACS Chemical Neuroscience
  80. The endocannabinoid system and the treatment of obesity
    Uberto Pagotto, Valentina Vicennati, Renato Pasquali · 2005 · Annals of Medicine
  81. Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance
    David P. Finn · 2009 · Immunobiology
  82. Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future
    George Panagis, Brian Mackey, Styliani Vlachou · 2014 · Frontiers in Psychiatry
  83. Endocannabinoids, cannabinoids and the regulation of anxiety
    Gavin N. Petrie, Andrei S. Nastase, Robert J. Aukema, Matthew N. Hill · 2021 · Neuropharmacology
  84. Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels
    Daniel K. Nomura, Carolyn S. S. Hudak, Anna M. Ward, James J. Burston, Roger S. Issa, Karl J. Fisher, Mary E. Abood, Jenny L. Wiley, Aron H. Lichtman, John E. Casida · 2008 · Bioorganic & Medicinal Chemistry Letters
  85. Cannabinol and cannabidiol exert opposing effects on rat feeding patterns
    Jonathan A. Farrimond, Benjamin J. Whalley, Claire Michelle Williams · 2012 · Psychopharmacology
  86. Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice
    Steven G. Kinsey, Pattipati S. Naidu, Benjamin F. Cravatt, David T. Dudley, Aron H. Lichtman · 2011 · Pharmacology Biochemistry and Behavior
  87. The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice
    Bogna Marta Ignatowska-Jankowska, Pretal P. Muldoon, Aron H. Lichtman, Mohamad Imad Damaj · 2013 · Psychopharmacology
  88. Fatty Acid Amide Hydrolase: From Characterization to Therapeutics
    Geoffray Labar, Catherine Michaux · 2007 · Chemistry & Biodiversity
  89. Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation
    Kathleen L. McCoy · 2016 · Mediators of Inflammation
  90. Identification of Endocannabinoids and Related Compounds in Human Fat Cells
    Marie‐Paule Gonthier, Laurence Hoareau, Franck Festy, Isabel Matias, Marta Valenti, Sandrine Bès-Houtmann, Claude Rouch, Christine Robert Da Silva, Serge Chesne, Christian Lefebvre d’Hellencourt et al. · 2007 · Obesity
  91. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview
    Balapal S. Basavarajappa, Basalingappa L. Hungund · 2002 · Prostaglandins Leukotrienes and Essential Fatty Acids
  92. Chapter 5 The Endocannabinoid System as A Target for Novel Anxiolytic and Antidepressant Drugs
    Gaetani, Silvana, Dipasquale, Pasqua, Romano, Adele, Righetti, Laura, Cassano, Tommaso, Piomelli, Daniele, Cuomo, Vincenzo · 2009 · International Review of Neurobiology
  93. The endocannabinoid system: Overview of an emerging multi-faceted therapeutic target
    Dipanjan Chanda, Dietbert Neumann, Jan F. C. Glatz · 2018 · Prostaglandins Leukotrienes and Essential Fatty Acids
  94. Cannabidiol modulation of oxidative stress and signalling
    Sónia R. Pereira, Becky Hackett, David N. O’Driscoll, Melody Cui Sun, Eric J. Downer · 2021 · Neuronal Signaling
  95. Group XV phospholipase A2, a lysosomal phospholipase A2
    James Alan Shayman, Robert Kelly, Jessica Kollmeyer, Yongqun Oliver He, Akira Abe · 2010 · Progress in Lipid Research
  96. Endocannabinoid System: Chemical Characteristics and Biological Activity
    Bismarck Rezende, Allan K. N. Alencar, Graziele Freitas de Bem, Fabrícia Lima Fontes-Dantas, Guilherme Carneiro Montes · 2023 · Pharmaceuticals
  97. Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non‐tumour brain tissue
    Gitte Lindved Petersen, Birthe Moesgaard, Patricia C. Schmid · 2005 · Journal of Neurochemistry
  98. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1receptor antagonism ? or inverse agonism ? as potential obesity treatment and other therapeutic use
    Shan Xie, M. A. Furjanic, Jarrod Ferrara, N. R. McAndrew, E. L. Ardino, A. Ngondara, Y. Bernstein, K. J. Thomas, E. Kim, J. M. Walker et al. · 2007 · Journal of Clinical Pharmacy and Therapeutics
  99. Effect of dietary fat on endocannabinoids and related mediators: Consequences on energy homeostasis, inflammation and mood
    Sebastiano Banni, Vincenzo Di Marzo · 2009 · Molecular Nutrition & Food Research
  100. Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids
    Rebecca A. Kohnz, Daniel K. Nomura · 2014 · Chemical Society Reviews